Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
44 /100
MEDIUM RISK
Score updated Oct 27, 2026

ADVB — Advanced Biomed Inc. Dilution Risk Tracker

Track ADVB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ADVB — Get alerts when the score changes →

As of October 27, 2026, Advanced Biomed Inc. (ADVB) has a DilutionWatch DilutionScore of 44/100, rated MEDIUM dilution risk. Advanced Biomed Inc. has a market capitalization of $4.59M, 1.65M shares outstanding, 3 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
40
📊 Float Risk
65
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ADVB.
🔔 Track ADVB — Get forecast alerts →

Market Data

Market Cap$4.59M
Shares Outstanding1.65M
Float629.7K
Cash$2.60M
Debt$712.5K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore44/100DilutionWatch score record
Shares Outstanding1.65MVerified float table or market cache
Public Float629.7KVerified float table or market cache
Market Cap$4.59MMarket data cache
Cash Runway17.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 4.

Recent SEC source mix: 8-K 3, 8-K/A 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

ADVB SEC Filing Activity — Last 12 Months

Shares outstanding reported by ADVB on the cover page of its latest 10-K/10-Q: 1.65M as of October 13, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for ADVB in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
8-Kcurrent report (material event)11Jul 17, 2026
10-Kannual report2Oct 13, 2026
10-Qquarterly report1May 15, 2026
DEF 14Aproxy statement1Jun 04, 2026
SC 13Gpassive >5% holder filing2Sep 22, 2026
SC 13G/Aamended passive >5% holder filing1Aug 20, 2026
4insider transaction1Aug 20, 2026

Institutional Holdings

QoQ: ↓ 83.2% shares (2025Q4 vs prior)
3 institutional holders · 44.1K shares
#1 XTX Topco Ltd 27.3K shares
#2 Virtu Financial LLC 12.6K shares
#3 UBS Group AG 4.3K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest9.7K
Days to Cover1.0
% of Float1.6%
FINRA data as of Oct 15, 2026

Recent SEC Activity

8-K 8K EVENT 2026-05-01
8-K 8K EVENT 2026-04-03
8-K/A 8K EVENT 2026-02-10
8-K 8K EVENT 2026-02-02
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ADVB Dilution Snapshot

Advanced Biomed Inc. (ADVB) has a DilutionScore of 44/100, rated Medium dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ADVB's DilutionScore is currently 44/100 (Medium risk), with 5 score changes tracked over 89 days. The score improved from 41/100 (Medium risk).

Period Score Risk Level Duration
Oct 22 – Oct 27, 202644/100MEDIUM6 days
Oct 14 – Oct 21, 202641/100MEDIUM8 days
Sep 28 – Oct 13, 202654/100HIGH16 days
Aug 22 – Sep 27, 202655/100HIGH37 days
Aug 14 – Aug 21, 202654/100HIGH7 days
Jul 30 – Aug 13, 202655/100HIGH15 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ADVB shares outstanding have decreased 0.0% from 1.63M (May 2026) to 1.63M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 20261.63M629.7K▲ 1.30%
May 17, 20261.63M621.6K▲ 68.54%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ADVB Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ADVB files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ADVB — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ADVB
ADVB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.